New allergy shot tested in teens: early safety check
NCT ID NCT07148557
First seen Feb 18, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This early-stage study tests a new injection called LP-003 in 6 adolescents aged 12 to 18 with allergies like hay fever, asthma, or eczema. The main goal is to check safety and how the drug moves through the body. It is too early to know if it works, but results will guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLERGIC DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Anhui Medical University
Hefei, China
Conditions
Explore the condition pages connected to this study.